by Maria Zannes | Jul 13, 2016 | News
JULY 13, 2016 As published in the San Antonio Business Journal By W. Scott Bailey One of San Antonio’s more promising bioscience companies, bioAffinity Technologies Inc., has locked up a key deal, renewing its collaborative agreement with the University of Texas...
by Maria Zannes | Jul 13, 2016 | Press Releases
JULY 13, 2016 (SAN ANTONIO, TX) bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio for research and development of novel cancer diagnostic and therapeutic agents using...
by Maria Zannes | Jul 8, 2016 | News
JULY 8, 2016 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio’s bioAffinity Technologies Inc. has hired a senior executive with strong ties to the city’s bioscience industry to help lead its new subsidiary — OncoSelect...
by Maria Zannes | Jul 7, 2016 | Press Releases
JULY 7, 2016 (SAN ANTONIO, TX) bioAffinity Technologies today announced that William Bauta, Ph.D., will join the company in September 2016 as Senior Vice President for Research and Development, Therapeutics. Dr. Bauta will direct the development and commercialization...
by Maria Zannes | Jun 23, 2016 | Press Releases
JUNE 23, 2016 (SAN ANTONIO, TX ) bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s proprietary porphyrin-based diagnostic technology to target a variety of cancers for...
